Latest News about biotech
Recent news which mentions biotech
From Benzinga
What's Going On With Panbela Therapeutics Stock?
January 26, 2024
From Benzinga
PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe
January 26, 2024
From Benzinga
Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation
January 26, 2024
From Benzinga
From Benzinga
Early IPO Activity Could Spell Bullishness for Biotech Industry
January 26, 2024
From ETF Trends
Eli Lilly's Famed Obesity And Diabetes Drug, Mounjaro, Comes To UK Patients, Wins Regulatory Clearance For Prefilled Injection Pen
January 25, 2024
From Benzinga
Axsome Depression Drug's Commercial Success, Pipeline Potential Undervalued, Analyst Says
January 25, 2024
From Benzinga
From Benzinga
From Benzinga
What's Going On With Pfizer Stock Today?
January 25, 2024
From Benzinga
Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
January 25, 2024
From Benzinga
InMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet Need
January 25, 2024
Tickers
INM
From Benzinga
Australian Psychiatrists Provide First Psychedelic-Assisted Medical Treatments In 50 Years
January 24, 2024
From Benzinga
Slow Market Penetration For Biogen's Another Alzheimer's Drug: UBS Highlights Risks, Forecasts
January 24, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.